Vanguard Global Advisers’s Kestra Medical Technologies KMTS Stock Holding History
Bought
Maintained
Sold
Other funds holding KMTS
YF
Vanguard Global Advisers's KMTS Position: Q3 2026 in Review
Vanguard Global Advisers increased its Kestra Medical Technologies (KMTS) stake by 79% in Q3 2026, buying an estimated $146K and bringing the position to 12,967 shares worth $367K. The position accounts for ﹤0.01% of the portfolio, ranked #2235.
Vanguard Global Advisers first reported a position in KMTS in Q1 2026 and has held it in 3 quarters since. 122 funds tracked by Wall St. Rank hold KMTS as of Q3 2026.
- Vanguard Global Advisers held 12,967 shares of Kestra Medical Technologies worth $367K as of Q3 2026.
- Vanguard Global Advisers bought 5,732 Kestra Medical Technologies shares in Q3 2026, an estimated $146K.
- Kestra Medical Technologies made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q3 2026, its #2235 holding.
- Vanguard Global Advisers first reported a position in Kestra Medical Technologies in Q1 2026 and has held it in 3 quarters since.
- 122 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q3 2026.
Based on Vanguard Global Advisers's 13F filing for Q3 2026, filed 13 Nov 2026.